Química e farmacologia de quimioterápicos antineoplásicos derivados de plantas

dc.creatorBrandão, Hugo N.
dc.creatorDavid, Juceni Pereira de Lima
dc.creatorCouto, Ricardo David
dc.creatorNascimento, Jorge A. P.
dc.creatorDavid, Jorge Mauricio
dc.creatorBrandão, Hugo N.
dc.creatorDavid, Juceni Pereira de Lima
dc.creatorCouto, Ricardo David
dc.creatorNascimento, Jorge A. P.
dc.creatorDavid, Jorge Mauricio
dc.date.accessioned2011-11-21T11:03:23Z
dc.date.accessioned2022-10-07T14:41:15Z
dc.date.available2011-11-21T11:03:23Z
dc.date.available2022-10-07T14:41:15Z
dc.date.created2011-11-21T11:03:23Z
dc.date.issued2010
dc.identifier0100-4042
dc.identifierhttp://www.repositorio.ufba.br/ri/handle/ri/3782
dc.identifierv. 33, n. 6.
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/4002856
dc.description.abstractThis review demonstrates the importance of plants as sources of molecules used in anticancer therapies. The approach is performed by relating the active molecules to their origins, details, mechanisms of action, structure-activity relationship and chemical characteristics of chemotherapeutical medicines. It was also described the development of anticancer agents from plants by the pharmaceutical industry and the difficulties to release these compounds as a trademark. These include the well known paclitaxel, docetaxel, vincristine, vinblastine, vinorelbine, vindesine, etoposide, teniposide, and other molecules that are undergoing clinical trials.
dc.languagept_BR
dc.subjectPlant antineoplasics
dc.subjectChemotherapic
dc.subjectCancer
dc.titleQuímica e farmacologia de quimioterápicos antineoplásicos derivados de plantas
dc.typeArtigo de Periódico


Este ítem pertenece a la siguiente institución